O uso de probióticos nas doenças inflamatórias intestinais

Abstract

The Inflammatory Bowel Diseases (IBD) is a group of chronic diseases of unknown etiology that has two main forms of presentation: Crohn's disease (CD) and Ulcerative Colitis (UC). The causes of Crohn's disease and ulcerative colitis are still undetermined, which by virtue of presenting epidemiological, genetic, immunological, clinical and therapeutic common, are included in the same disease. Epidemiological data show a marked increase in the incidence of the disease in the southern hemisphere, although it continues to be more prevalent in northern countries and higher socioeconomic strata. In recent years, with technological advances, the diagnosis has been facilitated. The intestinal microbiota plays an important role in human health. In some moments this equilibrium is not achieved and for this reason dietary supplementation with probiotics is necessary to ensure a favorable microbiota, such as in antimicrobial therapy for the treatment of bacterial infections. Currently, with the introduction of therapeutic with probiotics, the use of these microorganisms beneficial to health, has been quite effective in prolonging the remission of IBD, allowing a significantly improves in the quality of life of patients. The present study describes some concepts of their substances and the benefits they confer to human health, especially in the recovery of intestinal microbiota